Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6C3R

Cricket paralysis virus RNAi suppressor protein CrPV-1A

Summary for 6C3R
Entry DOI10.2210/pdb6c3r/pdb
DescriptorCricket paralysis virus 1A protein (2 entities in total)
Functional Keywordsrnai inhibitor, viral protein
Biological sourceCricket paralysis virus (isolate Teleogryllus commodus/Australia/CrPVVIC/1968)
Total number of polymer chains2
Total formula weight33583.90
Authors
Nayak, A.,Kim, D.Y.,Andino, R.,Gross, J. (deposition date: 2018-01-10, release date: 2018-10-17, Last modification date: 2024-10-30)
Primary citationNayak, A.,Kim, D.Y.,Trnka, M.J.,Kerr, C.H.,Lidsky, P.V.,Stanley, D.J.,Rivera, B.M.,Li, K.H.,Burlingame, A.L.,Jan, E.,Frydman, J.,Gross, J.D.,Andino, R.
A Viral Protein Restricts Drosophila RNAi Immunity by Regulating Argonaute Activity and Stability.
Cell Host Microbe, 24:542-557.e9, 2018
Cited by
PubMed Abstract: The dicistrovirus, Cricket paralysis virus (CrPV) encodes an RNA interference (RNAi) suppressor, 1A, which modulates viral virulence. Using the Drosophila model, we combined structural, biochemical, and virological approaches to elucidate the strategies by which CrPV-1A restricts RNAi immunity. The atomic resolution structure of CrPV-1A uncovered a flexible loop that interacts with Argonaute 2 (Ago-2), thereby inhibiting Ago-2 endonuclease-dependent immunity. Mutations disrupting Ago-2 binding attenuates viral pathogenesis in wild-type but not Ago-2-deficient flies. CrPV-1A also contains a BC-box motif that enables the virus to hijack a host Cul2-Rbx1-EloBC ubiquitin ligase complex, which promotes Ago-2 degradation and virus replication. Our study uncovers a viral-based dual regulatory program that restricts antiviral immunity by direct interaction with and modulation of host proteins. While the direct inhibition of Ago-2 activity provides an efficient mechanism to establish infection, the recruitment of a ubiquitin ligase complex enables CrPV-1A to amplify Ago-2 inactivation to restrict further antiviral RNAi immunity.
PubMed: 30308158
DOI: 10.1016/j.chom.2018.09.006
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.6 Å)
Structure validation

238895

数据于2025-07-16公开中

PDB statisticsPDBj update infoContact PDBjnumon